Fierce Pharma
OCTOBER 25, 2024
Despite Merck & Co. | Despite Merck & Co. homing in on approval for its infant respiratory syncytial virus antibody clesrovimab, Sanofi thinks Beyfortus can hold its own. On a Friday call with analysts, Sanofi execs pointed to an efficacy edge for its preventive and stressed that more competition in the space is a net positive.
MedCity News
OCTOBER 25, 2024
This week at HLTH, Dexcom COO Jake Leach discussed Stelo, his company’s new product. Stelo is an over-the-counter continuous glucose monitor meant for all adults who don’t take insulin. The post CGMs Aren’t Just for People with Diabetes Anymore, Dexcom COO Says appeared first on MedCity News.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
OCTOBER 25, 2024
A senior executive at BeiGene is under investigation by Chinese authorities, multiple local media outlets report. | A senior executive at BeiGene is under investigation by Chinese authorities, multiple local media outlets report. The company said it believes the investigation is not related to its activities.
MedCity News
OCTOBER 25, 2024
Septerna’s lead program is in Phase 1 testing for hypoparathyroidism. The therapies available and in development for this rare disease are injectable, and Septerna aims to stand apart with an oral GPCR-targeting small molecule. The post Septerna’s Upsized IPO Brings In $288M to Support a Pipeline of GPCR Drugs appeared first on MedCity News.
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
Fierce Pharma
OCTOBER 25, 2024
Despite recent concerns from the FDA about potential off-label use and antimicrobial resistance, Dublin-based Iterum Therapeutics has scored a green light for its oral antibiotic sulopenem. | Iterum's Orlynvah was approved by the FDA Friday to treat certain uncomplicated urinary tract infections (uUTIs) in adult women who have limited or no alternative antibacterial treatment options.
MedCity News
OCTOBER 25, 2024
A healthcare CRM is much more than a data management tool. It helps you make a strong first impression on each patient and strengthen relationships over time. The post The 3-Pronged Strategy to Boost Patient Engagement with Your CRM appeared first on MedCity News.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
MedCity News
OCTOBER 25, 2024
How are employers tackling the current landscape of healthcare costs? We turned to Shawn Gremminger, CEO of the National Alliance of Healthcare Purchaser Coalitions, a group of regional coalitions representing self-insured employers large and small that cover roughly 40 million people. The post MedCity Pivot Podcast: Chat With Shawn Gremminger About Employer-Led Healthcare appeared first on MedCity News.
pharmaphorum
OCTOBER 25, 2024
GSK has made another investment in its manufacturing network, setting aside $800 million to build two plants at its Marietta site in the US.The programme represents the largest capital spend by the UK drugmaker on production capacity to date and will double the size and capacity of GSK's existing medicines and vaccines facility in Marietta, Pennsylvania, creating around 200 new jobs.
European Pharmaceutical Review
OCTOBER 25, 2024
New clinical data has shown a potential best-in-class next-generation antibody-drug conjugate (ADC) can offer promising response rates in extensive-stage small cell lung cancer. The biologic ZL-1310 is being investigated in an ongoing Phase Ia/Ib study in these patients who have had at least one platinum-based chemotherapy regimen. Overall response rate was 74 percent in individuals with at least one post-treatment evaluation.
pharmaphorum
OCTOBER 25, 2024
Intellia reports a big reduction in hereditary angioedema attacks in patients treated with its one-shot CRISPR drug, but its share fall sharply
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Pharmaceutical Technology
OCTOBER 25, 2024
At the Outsourcing in Clinical Trials Conference, key opinion leaders shared predictions for workflow changes due to AI.
pharmaphorum
OCTOBER 25, 2024
MSD buys Modifi Bio in a $1.3bn deal, getting rights to a new class of drugs for difficult-to-treat cancers, including glioblastoma.
Pharmaceutical Technology
OCTOBER 25, 2024
A new vaccines drug substance facility and R&D pilot plant, completed by the end of 2028, will create over 200 new jobs.
pharmaphorum
OCTOBER 25, 2024
NICE backs two AI algorithms from Boston Scientific and Medtronic for monitoring heart failure patients, but turns down others from Biotronik and Abbott.
Advertisement
Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten
MedCity News
OCTOBER 25, 2024
What are hospitals trying to say with color today? Is it working? Maybe it’s not actually what patients want. And with that in mind, how might we build a more colorful future that changes this dynamic? The post Can Color Impact Healthcare Culture? appeared first on MedCity News.
Healthcare Success
OCTOBER 25, 2024
Despite the influx of digital technologies into virtually every aspect of our everyday lives, healthcare is still a very human business. As a result, healthcare providers still heavily rely on positive relationships with their referring doctors and other healthcare professionals (HCPs). While leading health systems and hospitals have long employed teams of on-the-ground “physician liaisons” to protect and grow their vital referral sources, today leading multilocation specialty practices do the s
Pharmaceutical Technology
OCTOBER 25, 2024
The funds will be used to advance Agomab’s candidates through clinical trials, including AGMB-129 for patients with fibrostenosing Crohn’s disease.
Pharma Marketing Network
OCTOBER 25, 2024
In an era wher Pharmaceutical digital marketing is in the middle of a rapid transformation. For pharma marketing executives , reaching audiences in meaningful, personalized ways has never been more critical. But with complex regulations, fast-evolving digital tools, and the challenges of building trust, it’s tough to know where to start. In this guide, we’ll break down the essentials of pharmaceutical digital marketing to help you navigate the unique challenges of the industry and maximize your
Scott Burrows
OCTOBER 25, 2024
In this blog we’ll be discussing the key steps of cultivating a success Mindset. Keep scrolling to read more. TORONTO, ON, October 5, 2019 – POV19 – The Power of One Conference Mindset: The Foundation of Success and Growth In both personal and professional development, one key factor consistently drives success: Mindset. As a keynote speaker and the author of Vision, Mindset, Grit , I’ve witnessed firsthand how a powerful mindset can turn obstacles into stepping stones an
PharmExec
OCTOBER 25, 2024
In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.
Scott Burrows
OCTOBER 25, 2024
In the fast-paced and often stressful world of healthcare, retreats have become a vital tool for rejuvenating professionals, fostering teamwork, and reigniting passion for patient care. These retreats provide an invaluable opportunity to step away from daily routines, reflect, and recharge. As a motivational keynote speaker with a powerful personal journey, I am uniquely positioned to kick off healthcare retreats and inspire participants to embrace resilience and transformation.
PharmExec
OCTOBER 25, 2024
Despite a recent FDA Complete Response Letter issued to Lykos for midomafetamine capsules for the treatment of post-traumatic stress disorder, experts believe that the future is bright for psychedelic drugs that treat mental health conditions.
Advertisement
Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.
PharmaTech
OCTOBER 25, 2024
Pharmaceutical Technology Europe chats with Kevin Li, MBA, from BioDuro-Sundia about integrated services and the benefits these services can provide to pharma companies.
PharmExec
OCTOBER 25, 2024
Under terms of the deal, Richter will receive an upfront cash payment of $25 million, along with potential future development, regulatory, and commercialization milestones.
PharmaTech
OCTOBER 25, 2024
The laboratory is on the same site as BioDuro-Sundia’s new Compound Management Center, which was launched earlier in October 2024.
Pharmaceutical Technology
OCTOBER 25, 2024
Takeda and the Boston Medical Center (BMC) have announced a partnership aimed at decarbonisation across the healthcare ecosystem.
PharmExec
OCTOBER 25, 2024
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Pharmaceutical Technology
OCTOBER 25, 2024
Dyno has formed a new research partnership with Roche on the development of AAV gene therapy vectors for neurological diseases.
PharmExec
OCTOBER 25, 2024
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
PharmaTech
OCTOBER 25, 2024
The report highlights international regulators’ plans for the development and availability of vaccines to prevent and drugs to treat mpox.
Advertisement
Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A
Expert insights. Personalized for you.
261 
Let's personalize your content